Biosensors International Group, Ltd. is a leading medical technology manufacturer headquartered in Singapore, specializing in the development and production of advanced devices for interventional cardiology, heart surgery, and intensive care. With over 25 years of industry experience and a workforce of 101 to 200 employees, the company operates dedicated manufacturing facilities and R&D centers in Singapore, alongside European headquarters in Switzerland. The company is a pioneer in drug-eluting stent technology, notably through its BioMatrix and BioFreedom product lines. Their specialized capabilities include the proprietary Biolimus A9 drug coating—a highly lipophilic derivative of sirolimus—and the use of biodegradable Poly-Lactic Acid (PLA) polymer. Utilizing automated stent coating technology for direct surface deposition on their S-Stent stent platform, they provide high-precision solutions for complex cardiac procedures. In addition to its role as an OEM manufacturer, the company is a key licensor of proprietary drug-eluting stent technologies to global partners such as Terumo and Devax, Inc. Biosensors International maintains a strong international presence, including a strategic joint venture for distribution in the Chinese market.
OEM manufacturerOffers OEM services for customized brand manufacturing.
ODM manufacturerProvides ODM design and manufacturing solutions.
Patented technologyHolds multiple product or process patents.
High-tech enterpriseRecognized as a high-tech or innovative enterprise.
Contact
************
************
Customers
OMEGA HEALTH CARE
1,324 shipments
*******
No shipments
*****
No shipments
**********
No shipments
***********
No shipments
Unlock all 34 customers
Unlock
Ask AI about this supplier
Curious about this supplier? Ask AI for a quick overview.
Key export market
🇮🇳 India🇮🇳 India
🇧🇷 Brazil🇧🇷 Brazil
🇧🇩 Bangladesh🇧🇩 Bangladesh
🇨🇷 Costa Rica🇨🇷 Costa Rica
🇪🇨 Ecuador🇪🇨 Ecuador
🇺🇿 Uzbekistan🇺🇿 Uzbekistan
🇲🇽 Mexico🇲🇽 Mexico
🇵🇪 Peru🇵🇪 Peru
🇵🇰 Pakistan🇵🇰 Pakistan
🇲🇾 Malaysia🇲🇾 Malaysia
🇦🇷 Argentina🇦🇷 Argentina
🇩🇴 Dominican Republic🇩🇴 Dominican Republic
🇷🇺 Russia🇷🇺 Russia
🇦🇲 Armenia🇦🇲 Armenia
🇵🇦 Panama🇵🇦 Panama
🇨🇴 Colombia🇨🇴 Colombia
🇺🇦 Ukraine🇺🇦 Ukraine
🇸🇬 Singapore🇸🇬 Singapore
🇨🇭 Switzerland🇨🇭 Switzerland
🇭🇰 Hong Kong🇭🇰 Hong Kong
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Customers
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customers
Top 5 customers
This insight is only available in the Pro plan
Top 5 export countries
Reflecting the supplier's export experience in target countries
Top 5 export countries
This insight is only available in the Pro plan
Shipment count distribution
Reflecting the supplier's market business activity
All categories
Loading chart data...
Shipment count distribution
This insight is only available in the Pro plan
Export weight distribution (kg)
Reflecting the supplier's export scale
All categories
Loading chart data...
Export weight distribution (kg)
This insight is only available in the Pro plan
Export weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughs
All categories
Loading chart data...
Export weight trend (kg)
This insight is only available in the Pro plan
CIF trend (USD)
For identifying high-value cooperation periods and single order value changes
Bioscience (Tianjin) Diagnostic Technology Co., Ltd. is a high-tech enterprise specializing in the research, development, and manufacture of in-vitro diagnostic (IVD) instruments and reagents. Based in the Tianjin Dongli Economic Development Area, China, the company operates as a manufacturer and distributor with a workforce of 501 to 1,000 employees. Since its founding, the company has established a strong R&D presence, holding over 130 patents and maintaining collaborations with leading academic universities to advance medical science and technology.
The company's core product portfolio focuses on advanced immunoassay systems, including Chemiluminescence Immunoassay (CLIA) and Fluorescence Immunoassay (FIA) analyzers. Key offerings include the Axceed 260 automatic immunoassay analyzer and various Point-of-Care Testing (POCT) devices designed for rapid clinical diagnostics. These instruments are supported by a comprehensive range of diagnostic test kits covering tumor markers, cardiac markers, infectious diseases (including COVID-19 and Monkeypox), thyroid function, endocrine disorders, and fertility screening.
Bioscience (Tianjin) operates a factory equipped with hundred-thousand-degree purification production departments and maintains ISO 13485 certification, ensuring international quality standards for medical device manufacturing. As an active participant in global trade, the company provides OEM services and exports its diagnostic solutions to over 25 countries, including major markets in India, the Philippines, and Ukraine. Their business model integrates full-lifecycle support, from independent intellectual property development to technical marketing and after-sales assistance.
Time-Resolved Fluoroimmunoassay Analyzer$1000
Shenzhen New Industries Biomedical Engineering Co., Ltd
🇨🇳 China
19952001-5000 peopleManufacturer
High capacity factory
Established brand
Large enterprise group
High-tech enterprise
Shipments
82877
Key customer
SNIBE DIAGNOSTIC
Key market
🇮🇳 India
Description
Shenzhen New Industries Biomedical Engineering Co., Ltd. (SNIBE), established in December 1995, is a national high-tech enterprise and manufacturer based in Shenzhen, China. With a workforce of 2,001 to 5,000 employees, SNIBE specializes in the R&D, production, sales, and service of in-vitro diagnostic products, with a primary focus on chemiluminescence immunoassay. The company operates a factory and offers OEM services. SNIBE provides a comprehensive range of clinical laboratory instruments and in-vitro diagnostic reagents, including immunoassay analyzers (e.g., MAGLUMI X series), biochemistry analyzers (e.g., Biossays C series), coagulation analyzers (e.g., Hemolumi H6), and electrolyte analyzers (Biossays E6 Plus). They also offer integrated laboratory solutions such as the SATLARS T8 fully automated intelligent assembly line and molecular diagnostic analyzers. SNIBE holds numerous certifications, including ISO 9001, ISO 13485, CE, EMC DIRECTIVE, and FSC, along with FDA clearance and CE List A for various assays. Their products are utilized in over 160 countries and regions globally, with over 30,000 fully automatic chemiluminescence analyzers installed worldwide.